Free Trial

Thermo Fisher Scientific (TMO) Competitors

Thermo Fisher Scientific logo
$489.49 +4.94 (+1.02%)
Closing price 03:59 PM Eastern
Extended Trading
$486.50 -2.99 (-0.61%)
As of 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TMO vs. MEDP, A, AMN, DHR, HAE, MCK, QGEN, WST, MTD, and WAT

Should you be buying Thermo Fisher Scientific stock or one of its competitors? The main competitors of Thermo Fisher Scientific include Medpace (MEDP), Agilent Technologies (A), AMN Healthcare Services (AMN), Danaher (DHR), Haemonetics (HAE), McKesson (MCK), Qiagen (QGEN), West Pharmaceutical Services (WST), Mettler-Toledo International (MTD), and Waters (WAT). These companies are all part of the "medical" sector.

Thermo Fisher Scientific vs. Its Competitors

Medpace (NASDAQ:MEDP) and Thermo Fisher Scientific (NYSE:TMO) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, media sentiment, earnings, dividends and profitability.

Medpace presently has a consensus target price of $412.73, suggesting a potential downside of 14.43%. Thermo Fisher Scientific has a consensus target price of $589.38, suggesting a potential upside of 20.41%. Given Thermo Fisher Scientific's stronger consensus rating and higher probable upside, analysts clearly believe Thermo Fisher Scientific is more favorable than Medpace.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medpace
3 Sell rating(s)
11 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.94
Thermo Fisher Scientific
0 Sell rating(s)
6 Hold rating(s)
16 Buy rating(s)
0 Strong Buy rating(s)
2.73

Medpace has a beta of 1.44, indicating that its share price is 44% more volatile than the S&P 500. Comparatively, Thermo Fisher Scientific has a beta of 0.75, indicating that its share price is 25% less volatile than the S&P 500.

Thermo Fisher Scientific has higher revenue and earnings than Medpace. Thermo Fisher Scientific is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medpace$2.11B6.42$404.39M$13.4535.86
Thermo Fisher Scientific$42.88B4.31$6.34B$17.2928.31

Medpace has a net margin of 18.74% compared to Thermo Fisher Scientific's net margin of 15.24%. Medpace's return on equity of 67.66% beat Thermo Fisher Scientific's return on equity.

Company Net Margins Return on Equity Return on Assets
Medpace18.74% 67.66% 21.86%
Thermo Fisher Scientific 15.24%16.82%8.38%

In the previous week, Thermo Fisher Scientific had 15 more articles in the media than Medpace. MarketBeat recorded 43 mentions for Thermo Fisher Scientific and 28 mentions for Medpace. Thermo Fisher Scientific's average media sentiment score of 1.23 beat Medpace's score of 1.11 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Medpace
21 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Thermo Fisher Scientific
36 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

78.0% of Medpace shares are held by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are held by institutional investors. 20.3% of Medpace shares are held by insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Thermo Fisher Scientific beats Medpace on 9 of the 16 factors compared between the two stocks.

Get Thermo Fisher Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for TMO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TMO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TMO vs. The Competition

MetricThermo Fisher ScientificMED INSTRUMENTS IndustryMedical SectorNYSE Exchange
Market Cap$182.97B$6.90B$5.75B$21.26B
Dividend Yield0.35%1.22%6.67%3.52%
P/E Ratio28.3126.0678.4329.40
Price / Sales4.3170.07546.9449.02
Price / Cash16.1321.6037.0524.13
Price / Book3.784.9010.914.54
Net Income$6.34B$178.27M$3.29B$999.70M
7 Day Performance-0.23%-0.61%0.01%0.12%
1 Month Performance4.72%1.88%7.06%5.75%
1 Year Performance-20.00%9.93%50.09%14.88%

Thermo Fisher Scientific Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TMO
Thermo Fisher Scientific
4.9254 of 5 stars
$489.49
+1.0%
$589.38
+20.4%
-20.2%$182.97B$42.88B28.31125,000Positive News
Analyst Forecast
Insider Trade
MEDP
Medpace
4.5383 of 5 stars
$475.51
+0.5%
$406.60
-14.5%
+37.5%$13.36B$2.11B35.355,900News Coverage
Positive News
Analyst Downgrade
Insider Trade
A
Agilent Technologies
4.5574 of 5 stars
$125.63
+0.5%
$139.25
+10.8%
-10.0%$35.69B$6.79B29.4917,900Analyst Revision
AMN
AMN Healthcare Services
4.4502 of 5 stars
$20.77
+3.6%
$28.25
+36.0%
-62.4%$795.98M$2.98B-2.672,968Positive News
DHR
Danaher
4.9247 of 5 stars
$206.09
+0.4%
$247.61
+20.1%
-24.5%$147.57B$23.88B43.8563,000News Coverage
Positive News
Analyst Forecast
HAE
Haemonetics
4.8094 of 5 stars
$54.63
+0.5%
$85.18
+55.9%
-28.9%$2.63B$1.36B16.712,820Positive News
Short Interest ↑
MCK
McKesson
4.5096 of 5 stars
$686.44
+0.8%
$725.10
+5.6%
+20.2%$85.38B$377.60B27.3745,000Positive News
Analyst Revision
QGEN
Qiagen
4.276 of 5 stars
$46.53
+0.9%
$49.69
+6.8%
+8.4%$10.34B$2.04B27.495,765
WST
West Pharmaceutical Services
4.9616 of 5 stars
$247.18
+0.7%
$320.71
+29.7%
-18.3%$17.77B$2.96B37.0010,600Positive News
MTD
Mettler-Toledo International
4.2989 of 5 stars
$1,302.74
+1.5%
$1,311.11
+0.6%
-9.4%$26.84B$3.87B32.9917,300Positive News
WAT
Waters
4.711 of 5 stars
$301.89
+1.4%
$378.73
+25.5%
-14.7%$17.97B$2.96B27.227,600Trending News

Related Companies and Tools


This page (NYSE:TMO) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners